ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
TG Therapeutics Inc

TG Therapeutics Inc (TGTX)

33.50
0.05
( 0.15% )
更新日時: 05:47:21

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
33.50
買値
33.49
売値
33.51
出来高
1,584,502
33.05 日の範囲 34.04
12.84 52 週間の範囲 36.84
時価総額
前日終値
33.45
始値
33.32
最終取引時間
05:47:29
財務取引量
US$ 53,165,344
VWAP
33.5533
平均取引量 (3 か月)
2,841,711
発行済株式数
155,665,334
配当利回り
-
PER
416.83
1 株当たり利益 (EPS)
0.08
歳入
233.66M
純利益
12.67M

TG Therapeutics Inc について

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, ... TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a unique epitope on the CD20 antigen found on mature B-lymphocytes. It is also developing TGR-1202 (umbralisib), an orally available PI3K delta inhibitor. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
TG Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TGTX. The last closing price for TG Therapeutics was US$33.45. Over the last year, TG Therapeutics shares have traded in a share price range of US$ 12.84 to US$ 36.84.

TG Therapeutics currently has 155,665,334 shares in issue. The market capitalisation of TG Therapeutics is US$5.21 billion. TG Therapeutics has a price to earnings ratio (PE ratio) of 416.83.

TG Therapeutics (TGTX) のオプションフロー概要

全体の流れ

ブルリッシュ

ネットプレミアム

616k

Calls / Puts

1,200.00%

買い / 売り

18.18%

OTM / ITM

30.00%

Sweeps比率

0.00%

TGTX 最新ニュース

TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones

Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue of $103.6 million and $310 million, respectively Full Year 2025 target total global revenue of approximately $540...

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the...

TG Therapeutics to Participate in the Evercore HealthCONx Conference

NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in...

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number one on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
13.6912.378396511229.8133.4928.44248653731.72960057CS
42.8059.1382961394430.69533.4927.24282368329.70183118CS
126.825.46816479426.736.8426.15284171131.38809448CS
2612.8562.227602905620.6536.8416.8901327101626.26405689CS
5217.67111.62349968415.8336.8412.84325515421.35186906CS
15623.61238.7259858449.8936.843.48386086715.23285221CS
26019.25135.08771929814.2556.743.48301499218.04086472CS

TGTX - Frequently Asked Questions (FAQ)

What is the current TG Therapeutics share price?
The current share price of TG Therapeutics is US$ 33.50
How many TG Therapeutics shares are in issue?
TG Therapeutics has 155,665,334 shares in issue
What is the market cap of TG Therapeutics?
The market capitalisation of TG Therapeutics is USD 5.21B
What is the 1 year trading range for TG Therapeutics share price?
TG Therapeutics has traded in the range of US$ 12.84 to US$ 36.84 during the past year
What is the PE ratio of TG Therapeutics?
The price to earnings ratio of TG Therapeutics is 416.83
What is the cash to sales ratio of TG Therapeutics?
The cash to sales ratio of TG Therapeutics is 22.6
What is the reporting currency for TG Therapeutics?
TG Therapeutics reports financial results in USD
What is the latest annual turnover for TG Therapeutics?
The latest annual turnover of TG Therapeutics is USD 233.66M
What is the latest annual profit for TG Therapeutics?
The latest annual profit of TG Therapeutics is USD 12.67M
What is the registered address of TG Therapeutics?
The registered address for TG Therapeutics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the TG Therapeutics website address?
The website address for TG Therapeutics is www.tgtherapeutics.com
Which industry sector does TG Therapeutics operate in?
TG Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
US$ 0.00
(0.00%)
0
AACGATA Creativity Global
US$ 0.00
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
US$ 0.00
(0.00%)
0
AACGATA Creativity Global
US$ 0.00
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
US$ 0.00
(0.00%)
0
AACGATA Creativity Global
US$ 0.00
(0.00%)
0

TGTX Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock